Your shopping cart is currently empty

Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a lesser extent VEGFR-1, which are important targets in thyroid cancer (TC).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 1-2 weeks | 1-2 weeks | |
| 50 mg | $2,180 | 1-2 weeks | 1-2 weeks | |
| 100 mg | $2,800 | 1-2 weeks | 1-2 weeks |
| Description | Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a lesser extent VEGFR-1, which are important targets in thyroid cancer (TC). |
| Synonyms | ZD 6474, Zactima, Vandetanib, HSDB 8198, Caprelsa |
| Molecular Weight | 591.43 |
| Formula | C26H28BrFN4O6 |
| Cas No. | 338992-00-0 |
| Smiles | COC1=C(C=C2N=CN=C(C2=C1)NC3=C(C=C(C=C3)Br)F)OCC4CCN(CC4)C.O=C(/C=C/C(O)=O)O |
| Relative Density. | 1.406 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.